These may include: Nausea or bloating Constipation or diarrhea Headache or fatigue Injection site tenderness These effects usually decrease as your body adjusts to the medication
In updated patient information resources, the CMA notes that while Novo Nordisk's regulatory exclusivity for semaglutide ended on January 4, 2026, generic versions will not be available immediately on Canadian pharmacy shelves
The remaining reads (98% of all reads across all conditions) were aligned to the hg19 human reference genome using STAR
Hexosamine pathway Excess glucose not metabolized via glycolysis can enter the hexosamine pathway, which leads to increased production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is used for O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins
This powerful antioxidant is naturally produced by the body and plays a key role in detoxification and cellular protection
I am a yoga instructor for 19+ years